News tagged with monoclonal antibodies
Scientists engineer new type of vaccination that provides instant immunity
The experiments, thus far performed only in mice, appear to overcome a major drawback of vaccinations - the lag time of days, or even weeks, that it normally takes for immunity to build against a pathogen. This new method ...
Medicine & Health / Medical research
Mar 02, 2009 |
4.6 / 5 (19) |
0
Computer-designed proteins programmed to disarm variety of flu viruses
Computer-designed proteins are under construction to fight the flu. Researchers are demonstrating that proteins found in nature, but that do not normally bind the flu, can be engineered to act as broad-spectrum ...
13 hours ago |
5 / 5 (4) |
0
|
Nanoparticles may enhance cancer therapy
A mixture of current drugs and carbon nanoparticles shows potential to enhance treatment for head-and-neck cancers, especially when combined with radiation therapy, according to new research by Rice University ...
Nanotechnology / Bio & Medicine
Feb 16, 2012 |
5 / 5 (3) |
0
|
Detecting lethal diseases with rust and sand
The next big thing in medical diagnostics could be minutes particles of rust, iron oxide, coated with the material from which sand is formed, silicon dioxide. These magnetic nanoparticles, a mere 29 to 230 nanometers across, ...
Nanotechnology / Bio & Medicine
Jan 31, 2011 |
5 / 5 (2) |
0
|
Conversion of brain tumor cells into blood vessels thwarts treatment efforts
Glioblastoma, the most common and lethal form of brain cancer and the disease that killed Massachusetts Senator Ted Kennedy, resists nearly all treatment efforts, even when attacked simultaneously on several ...
Jan 24, 2011 |
5 / 5 (7) |
1
|
Detecting, treats tumors, and monitoring response to therapy with gold 'nano-popcorn'
Using a two-step process that creates gold nanoparticles that look like kernels of popcorn, researchers at Jackson State University have created a targeted nanoparticle that can detect as few as 50 malignant prostate cells ...
Nanotechnology / Bio & Medicine
Jan 19, 2011 |
3.5 / 5 (2) |
0
|
Researchers discover a potential target for therapy for patients with a deadly prostate cancer
A monoclonal antibody targeting a well known cell surface protein inhibited prostate cancer growth and metastasis in an aggressive form of the disease that did not respond to hormone therapy, according to a study by researchers ...
Nov 08, 2010 |
5 / 5 (2) |
0
|
Novel chemistry amplifies ability of nanoparticles to detect rare cells
One of the most promising characteristics of nanoparticles as diagnostic agents is the ability to attach to the nanoparticles surface any of a wide variety of targeting molecules that can increase the distinction between ...
Nanotechnology / Bio & Medicine
Sep 17, 2010 |
5 / 5 (2) |
0
|
Nanoporous Particles Deliver Novel Molecular Therapies to Tumors
(PhysOrg.com) -- Using nanoporous silicon particles, two teams of investigators have created drug delivery vehicles capable of ferrying labile molecular therapies deep into the body. Both groups believe their new drug delivery ...
Nanotechnology / Bio & Medicine
May 26, 2010 |
5 / 5 (1) |
0
|
Mapping Tumor Heterogeneity With Quantum Dots
(PhysOrg.com) -- One important discovery made about cancer over the past decade is that as a tumor develops, the molecular identity of its cells begins to diverge. As a result, any given tumor is likely to contain groups ...
Nanotechnology / Bio & Medicine
May 25, 2010 |
5 / 5 (2) |
0
|
Study shows potential for using algae to produce human therapeutic proteins
Pharmaceutical companies could substantially reduce the expense of costly treatments for cancer and other diseases produced from mammalian or bacterial cells by growing these human therapeutic proteins in ...
Mar 08, 2010 |
4 / 5 (2) |
1
|
Infection-fighting antibodies made in plants as effective as costlier conventional version
The first head-to-head comparison of therapeutic monoclonal antibodies produced from plants versus the same antibodies produced from mammalian cells has shown that plant-produced antibodies can fight infection equally well.
Medicine & Health / Medical research
Feb 08, 2010 |
4.7 / 5 (3) |
0
|
New cancer target for non-Hodgkin's lymphoma
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, ...
Nov 22, 2009 |
5 / 5 (1) |
0
Breakthrough in fight against Hendra virus
(PhysOrg.com) -- There has been a breakthrough in the fight against the deadly Hendra virus following the development of a treatment which shows great potential to save the lives of people who become infected ...
Oct 30, 2009 |
5 / 5 (1) |
0
First human gets new antibody aimed at hepatitis C virus
Building upon a series of successful preclinical studies, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) today announced the beginning of a Phase 1 clinical trial, testing the safety ...
Medicine & Health / Diseases, Conditions, Syndromes
Aug 06, 2009 |
5 / 5 (3) |
0
Monoclonal antibodies
Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are identical because they are produced by one type of immune cell that are all clones of a single parent cell. Given almost any substance, it is possible to create monoclonal antibodies that specifically bind to that substance; they can then serve to detect or purify that substance. This has become an important tool in biochemistry, molecular biology and medicine. When used as medications, the generic drug name ends in -mab (see "Nomenclature of monoclonal antibodies").
For more information about Monoclonal antibodies, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
